The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers
Nashville, Tennessee, United States
Medical clinic in Nashville, Tennessee
250 25th Ave N #412, Nashville, TN 37203
About The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Vertex Pharmaceuticals Incorporated
4
Celgene
2
Alpine Immune Sciences, Inc.
1
Juno Therapeutics, a Subsidiary of Celgene
1
Pfizer
1
Clinical Trials at The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers
During the past decade, The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
No longer available
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia
2018-09-14
2024-08-01
Active, not recruiting
45
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease
2018-11-27
2024-10-01
Active, not recruiting
45
A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)
2020-05-27
2023-12-14
Active, not recruiting
13
A Long-term Follow-up Study in Subjects Who Received CTX001
2021-01-20
2039-09-01
Enrolling by invitation
114
Study of ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD Versus Host Disease
2020-05-11
2020-05-21
Terminated
1
A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
2021-02-24
2025-06-07
Recruiting
180
Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma
2021-06-01
2026-12-06
Recruiting
312
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 4 trials, followed by "Celgene" with 2 trials
sponsored, "Alpine Immune Sciences, Inc." with 1 trials sponsored, "Juno Therapeutics, a Subsidiary of Celgene" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers"
#1 collaborator was "CRISPR Therapeutics" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers
According to Clinical.Site data, the most researched conditions in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" are
"Hemoglobinopathies" (4 trials), "Multiple Myeloma" (3 trials), "Sickle Cell Disease" (3 trials), "Beta-Thalassemia" (2 trials) and "Genetic Diseases, Inborn" (2 trials). Many other conditions were trialed in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" in a lesser frequency.
Clinical Trials Intervention Types at The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers
Most popular intervention types in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" are "Biological" (7 trials) and "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "CTX001" (4 trials), "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials), "ALPN-101" (1 trials) and "Antibody Drug Conjugate Chemotherapeutic" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers
The vast majority of trials in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers" are
9 trials for "All" genders.
Clinical Trials Status at The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers
Currently, there are NaN active trials in "The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were undefined completed trials in The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Children's Hospital at TriStar Centennial Medical Center/ Sarah Cannon Center for Blood Cancers, 4 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".